235 related articles for article (PubMed ID: 23660419)
1. Management of hepatitis B: our practice and how it relates to the guidelines.
Yapali S; Talaat N; Lok AS
Clin Gastroenterol Hepatol; 2014 Jan; 12(1):16-26. PubMed ID: 23660419
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of international guidelines for identifying significant fibrosis in hepatitis B e antigen--negative patients with chronic hepatitis.
Sanai FM; Babatin MA; Bzeizi KI; Alsohaibani F; Al-Hamoudi W; Alsaad KO; Al Mana H; Handoo FA; Al-Ashgar H; Alghamdi H; Ibrahim A; Aljumah A; Alalwan A; Altraif IH; Al-Hussaini H; Myers RP; Abdo AA
Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1493-1499.e2. PubMed ID: 23811251
[TBL] [Abstract][Full Text] [Related]
3. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
4. Selecting appropriate management strategies for chronic hepatitis B: who to treat.
McMahon BJ
Am J Gastroenterol; 2006; 101 Suppl 1():S7-12. PubMed ID: 16448451
[TBL] [Abstract][Full Text] [Related]
5. Treatment recommendations for chronic hepatitis B: an evaluation of current guidelines based on a natural history study in the United States.
Tong MJ; Hsien C; Hsu L; Sun HE; Blatt LM
Hepatology; 2008 Oct; 48(4):1070-8. PubMed ID: 18688879
[TBL] [Abstract][Full Text] [Related]
6. Implementing evidenced-based practice guidelines for the management of chronic hepatitis B virus infection.
McMahon BJ
Am J Med; 2008 Dec; 121(12 Suppl):S45-52. PubMed ID: 19185074
[TBL] [Abstract][Full Text] [Related]
7. Management of chronic hepatitis B in childhood: ESPGHAN clinical practice guidelines: consensus of an expert panel on behalf of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition.
Sokal EM; Paganelli M; Wirth S; Socha P; Vajro P; Lacaille F; Kelly D; Mieli-Vergani G;
J Hepatol; 2013 Oct; 59(4):814-29. PubMed ID: 23707367
[No Abstract] [Full Text] [Related]
8. Antiviral drugs for HBV liver disease.
Viganò M; Lampertico P
Expert Opin Biol Ther; 2011 Mar; 11(3):285-300. PubMed ID: 21204745
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of entecavir in chronic hepatitis B patients with mildly elevated alanine aminotransferase and biopsy-proven histological damage.
Wu IC; Lai CL; Han SH; Han KH; Gordon SC; Chao YC; Tan CK; Sievert W; Tanwandee T; Xu D; Neo BL; Chang TT
Hepatology; 2010 Apr; 51(4):1185-9. PubMed ID: 20044806
[TBL] [Abstract][Full Text] [Related]
10. INASL Position Statements on Prevention, Diagnosis and Management of Hepatitis B Virus Infection in India: The Andaman Statements.
Arora A; Singh SP; Kumar A; Saraswat VA; Aggarwal R; Bangar M; Bhaumik P; Devarbhavi H; Dhiman RK; Dixit VK; Goel A; Goswami B; Kapoor D; Madan K; Narayan J; Nijhawan S; Pandey G; Rai RR; Sahu MK; Saraf N; Shalimar ; Shenoy T; Thomas V; Wadhawan M;
J Clin Exp Hepatol; 2018 Mar; 8(1):58-80. PubMed ID: 29743798
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B in children: complexities in management.
Kerkar N
Pediatr Transplant; 2005 Oct; 9(5):685-91. PubMed ID: 16176431
[TBL] [Abstract][Full Text] [Related]
12. Combination of pegylated interferon and lamivudine for patients with chronic hepatitis B who have failed treatment.
Sarin SK; Kumar M; Hissar S; Sharma BC
Hepatobiliary Pancreat Dis Int; 2006 Aug; 5(3):374-80. PubMed ID: 16911934
[TBL] [Abstract][Full Text] [Related]
13. Unraveling the complexity of hepatitis B virus: from molecular understanding to therapeutic strategy in 50 years.
Liu B; Wen X; Huang C; Wei Y
Int J Biochem Cell Biol; 2013 Sep; 45(9):1987-96. PubMed ID: 23819994
[TBL] [Abstract][Full Text] [Related]
14. Chronic hepatitis B--who should be treated?
Coffin CS; Lee SS
MedGenMed; 2006 Mar; 8(1):75. PubMed ID: 16915205
[TBL] [Abstract][Full Text] [Related]
15. Management of chronic hepatitis B virus infection: a new era of disease control.
Farrell GC; Teoh NC
Intern Med J; 2006 Feb; 36(2):100-13. PubMed ID: 16472264
[TBL] [Abstract][Full Text] [Related]
16. Treatment of HBeAg positive chronic hepatitis B: interferon or nucleoside analogues.
Dusheiko G
Liver Int; 2013 Feb; 33 Suppl 1():137-50. PubMed ID: 23286858
[TBL] [Abstract][Full Text] [Related]
17. Chronic hepatitis B: recommendations for therapy based on the natural history of disease in Australian patients.
Bell SJ; Lau A; Thompson A; Watson KJ; Demediuk B; Shaw G; Chen RY; Ayres A; Yuen L; Bartholomeusz A; Locarnini SA; Desmond PV
J Clin Virol; 2005 Feb; 32(2):122-7. PubMed ID: 15653414
[TBL] [Abstract][Full Text] [Related]
18. [Chronic hepatitis B. Recent advances in diagnosis and treatment].
Bernardi M; Biselli M; Gramenzi A
Recenti Prog Med; 2002; 93(7-8):397-402. PubMed ID: 12138683
[TBL] [Abstract][Full Text] [Related]
19. Treatment of chronic hepatitis B in Asia-Pacific countries: is the Asia-Pacific consensus statement being followed?
Sung JJ; Amarapurkar D; Chan HL; Cheng J; Kao JH; Han KH; Piratvisuth T
Antivir Ther; 2010; 15(4):607-16. PubMed ID: 20587854
[TBL] [Abstract][Full Text] [Related]
20. A survey on the current trends in the management of hepatitis B in China.
Ning LH; Hao J; Liao ZL; Zhou YY; Guo H; Zhao XY
Eur J Gastroenterol Hepatol; 2012 Aug; 24(8):884-9. PubMed ID: 22569081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
